Sweeping review suggests weight-loss drugs’ effect on 175 conditions – The Washington Post

United States
  1. Sweeping review suggests weight-loss drugs’ effect on 175 conditions  The Washington Post
  2. Mapping the effectiveness and risks of GLP-1 receptor agonists  Nature.com
  3. Weight-loss jabs linked to reduced risk of 42 conditions including dementia  The Guardian
  4. Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind  Livescience.com
  5. Weight-loss drugs reduce risk of Alzheimer’s, large study shows  Financial Times

Leave a Comment

Your email address will not be published. Required fields are marked *